Decitabine

Decitabine and venetoclax for AML VJHemOnc – Video Journal of Hematology & HemOnc 1,663 4 года назад
Decitabine dosing regimens in older AML patients: 5-day vs. 10-day, is there a difference? VJHemOnc – Video Journal of Hematology & HemOnc 1,771 6 лет назад
Decitabine plus venetoclax is comparable to intensive chemotherapy in R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 270 3 года назад
Decitabine, venetoclax and ponatinib in patients with advanced CML and Ph+ AML VJHemOnc – Video Journal of Hematology & HemOnc 510 1 год назад
Decitabine, venetoclax, and IDH inhibitor in IDH-mutated AML VJHemOnc – Video Journal of Hematology & HemOnc 100 7 месяцев назад
Azacitidine and decitabine in treatment naive AML patients VJHemOnc – Video Journal of Hematology & HemOnc 2,675 4 года назад
Venetoclax with decitabine for high-risk AML and MDS VJHemOnc – Video Journal of Hematology & HemOnc 658 4 года назад
Phase I trial of decitabine plus ipilimumab in R/R MDS & AML VJHemOnc – Video Journal of Hematology & HemOnc 76 3 года назад
10-day ASTX727 (decitabine/cedazuridine) with venetoclax in the treatment of R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 171 8 месяцев назад
James Foran: Does Decitabine Maintenance Improve Survival in Older Patients With AML? American Society of Hematology 1,009 4 года назад
Optimizing HMA treatment in HR-MDS: azacitidine versus decitabine VJHemOnc – Video Journal of Hematology & HemOnc 95 6 месяцев назад
Oral combination of ASTX727 (decitabine/cedazuridine) plus Ven for older/unfit patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 74 8 месяцев назад
Safety and efficacy of sabatolimab plus azacitidine or decitabine in patients with HR-MDS and AML VJHemOnc – Video Journal of Hematology & HemOnc 173 2 года назад
Outcomes of TP53-mutant AML with venetoclax and decitabine VJHemOnc – Video Journal of Hematology & HemOnc 653 3 года назад
Exploring the safety & efficacy of magrolimab plus oral decitabine/cedazuridine in MDS VJHemOnc – Video Journal of Hematology & HemOnc 165 1 год назад
Real-world data: oral decitabine plus cedazuridine versus IV/SC hypomethylating agents VJHemOnc – Video Journal of Hematology & HemOnc 92 8 месяцев назад
TP53-mutant AML linked to poorer outcomes with decitabine plus venetoclax VJHemOnc – Video Journal of Hematology & HemOnc 292 3 года назад
Decitabine - Dacogen use in a nutshell. Pharma Guru 166 1 год назад